Skye Bioscience Inc (SKYE)
12.05
-0.20
(-1.63%)
USD |
NASDAQ |
May 17, 16:00
12.05
0.00 (0.00%)
After-Hours: 20:00
Skye Bioscience Cash from Financing (Quarterly): 85.65M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 85.65M |
| December 31, 2023 | -0.0227M |
| September 30, 2023 | 16.63M |
| June 30, 2023 | -0.1234M |
| March 31, 2023 | -0.0453M |
| December 31, 2022 | 0.0342M |
| September 30, 2022 | -0.0918M |
| June 30, 2022 | -0.0918M |
| March 31, 2022 | -0.0593M |
| December 31, 2021 | -0.0837M |
| September 30, 2021 | 7.416M |
| June 30, 2021 | 1.705M |
| March 31, 2021 | 4.042M |
| December 31, 2020 | 0.038M |
| September 30, 2020 | 6.096M |
| June 30, 2020 | 0.5667M |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 2.014M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 3.991M |
| December 31, 2018 | 1.809M |
| Date | Value |
|---|---|
| September 30, 2018 | 0.00 |
| June 30, 2018 | -0.0078M |
| March 31, 2018 | 3.740M |
| December 31, 2017 | 2.381M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 1.132M |
| December 31, 2016 | 0.4077M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | -0.0079M |
| September 30, 2015 | 5.038M |
| June 30, 2015 | 0.9923M |
| March 31, 2015 | 0.7211M |
| July 31, 2014 | 0.0492M |
| April 30, 2014 | 0.0002M |
| January 31, 2014 | -0.0016M |
| October 31, 2013 | 0.0238M |
| July 31, 2013 | -0.0118M |
| April 30, 2013 | 0.0096M |
| January 31, 2013 | 0.0568M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.1234M
Minimum
Jun 2023
85.65M
Maximum
Mar 2024
6.184M
Average
0.0171M
Median
Cash from Financing (Quarterly) Benchmarks
| Cutera Inc | -0.26M |
| Medical Marijuana Inc | -- |
| OrthoPediatrics Corp | -0.573M |
| RAPT Therapeutics Inc | 9.036M |
| NovaBay Pharmaceuticals Inc | -0.597M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.708M |
| Cash from Investing (Quarterly) | 1.142M |
| Free Cash Flow | -14.61M |
| Free Cash Flow Per Share (Quarterly) | -0.1683 |
| Free Cash Flow Yield | -9.31% |